Two cases of cerebral sinus venous thrombosis following chemotherapy for non-seminomatous germ cell tumor

Case Reports in Oncology

Volumn 4, Issue 3, 2011, Pages 555-559

  Papet, C ^a   Gutzeit, A ^a   Pless, M ^a  

^a CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

Author keywords

Cerebral sinus venous thrombosis; Cisplatin; Germ cell tumor

Indexed keywords

ANTICOAGULANT AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; DALTEPARIN; ETOPOSIDE; HEPARIN;

ADULT; ANAMNESIS; ANOREXIA; ARTICLE; ASTHENIA; CASE REPORT; CEREBRAL SINUS THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; DEHYDRATION; DIFFERENTIAL DIAGNOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEADACHE; HUMAN; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROLOGIC DISEASE; NON SEMINOMATOUS GERMINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORCHIECTOMY; PRIORITY JOURNAL; REHYDRATION; TESTIS CANCER;

EID: 84855317905     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000334850     Document Type: Article

References (14)

1. Weijl NI, Rutten MF, Zwinderman AH, Keizer HJ, Nooy MA, Rosendaal FR, Cleton FJ, Osanto S: Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature. J Clin Oncol 2000;18:2169-2178. (Pubitemid 30324370)
2. Piketty AC, Fléchon A, Laplanche A, Nouyrigat E, Droz JP, Théodore C, Fizazi K: The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area. Br J Cancer 2005;93:909-914. (Pubitemid 41487017)
3. Gerl A: Vascular toxicity associated with chemotherapy for testicular cancer. Anticancer Drugs 1994;5:607-614.
4. Schmoll HJ, Jordan K, Huddart R, Pes MP, Horwich A, Fizazi K, Kataja V; ESMO Guidelines Working Group: Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(suppl 5):v147-v154.
5. Stam J: Cerebral venous and sinus thrombosis: incidence and causes. Adv Neurol 2003;92:225-232.
6. Ferro JM: Causes, predictors of death, and antithrombotic treatment in cerebral venous thrombosis. Clin Adv Hematol Oncol 2006;4:732-733.
7. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F: Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664-670. (Pubitemid 38280838)
8. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY; American Heart Association Stroke Council and the Council on Epidemiology and Prevention: Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:1158-1192.
9. Ozen A, Cicin I, Sezer A, Uzunoglu S, Saynak M, Genchellac H, Karagol H: Dural sinus vein thrombosis in a patient with colon cancer treated with FOLFIRI/bevacizumab. J Cancer Res Ther 2009;5:130-132.
10. Vargo JA, Snelling BM, Ghareeb ER, John K, Frame JN, Schmidt JH, Peters KB: Dural venous sinus thrombosis in anaplastic astrocytoma following concurrent temozolomide and focal brain radiotherapy plus bevacizumab. J Neurooncol 2011;104:595-598.
11. Unal E, Yazar A, Koksal Y, Caliskan U, Paksoy Y, Kalkan E: Cerebral venous sinus thrombosis in an adolescent with Ewing sarcoma. Childs Nerv Syst 2008;24:983-986.
12. Basiri K, Dashti M, Fatehi F: Malignant cutaneous melanoma associated with cerebral venous sinus thrombosis. Neurosciences (Riyadh) 2010;15:190-192.
13. Karam C, Koussa S: Cerebral sinus thrombosis following cisplatin chemotherapy. J Clin Neurosci 2008;15:1274-1275.
14. Digklia A, Berthold D: A man presenting headache and photophobia while receiving BEP chemotherapy. Schweizer Krebsbulletin 2/2011;174-176.